Cathal Riordan
About Cathal Riordan
Cathal Riordan is the Associate Director of Program Management: Operational Excellence: GPD and S and G.Ops at Bristol-Myers Squibb, with over 20 years of experience in the bio/pharma industry.
Current Title and Role at Bristol-Myers Squibb
Cathal Riordan is currently the Associate Director Program Management: Operational Excellence: GPD and S and G.Ops at Bristol-Myers Squibb. In this role since April 2019, Cathal focuses on program management and operational excellence within the GPD and S & G.Ops divisions. His extensive background in the bio/pharma industry supports his contributions to the company's operational strategies.
Previous Experience at Primecore Program Management
From 2012 to 2013, Cathal Riordan served as a Program Manager at Primecore Program Management. During his 11-month tenure, Cathal was responsible for overseeing program initiatives and managing project timelines, ensuring the successful execution of objectives within the company.
Career at Pfizer
Cathal Riordan held multiple managerial roles at Pfizer over several years. From 2006 to 2009, he served as a Technology Transfer Manager and Development Manager. He then became a Project Lead and Technology Transfer Manager from 2009 to 2011. In these roles, Cathal managed technology transfer projects and led efforts to enhance development processes, contributing to Pfizer's operational improvements.
Technical and Antigen Production Manager at Fort Dodge Animal Health
Between 2003 and 2006, Cathal Riordan worked at Fort Dodge Animal Health in progressively advancing roles. Initially, he was a Technical Manager for two years, later becoming the Technical and Antigen Production Manager. Cathal led technical teams and managed antigen production, pivotal to the company's product development and manufacturing processes.
Academic Background and Postdoctoral Research
Cathal Riordan completed his higher education at Ulster University, earning a Bachelor of Science degree from 1991 to 1995 and a Doctor of Philosophy from 1995 to 1998. After obtaining his doctorate, he engaged in postdoctoral research at the University of Ulster from 1999 to 2001, further honing his expertise in scientific research and academia.
Industry Experience and Expertise
With over 20 years of experience in the bio/pharma industry, Cathal Riordan brings a wealth of knowledge to his current role. His career encompasses diverse positions, including a Principal Research Scientist at EFMB and various managerial roles in notable companies such as Pfizer and Fort Dodge Animal Health. His expertise in program management, technology transfer, and technical production underscores his substantial contributions to the sector.